Evidence map›Paper›PMID 33371119›Full record

ArticleMedicine2020

Coronavirus disease 2019 pandemic stress and its effects on irritable bowel syndrome patients in Saudi Arabia.

Mohammed A Alzahrani, Ali S Alshamrani, Ibrahim M Ahmasani, Fahad S Alahmari, Ali H Asiri, Abdullah M Alshehri, Awad S Alsamghan, Nabil J Awadalla

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Mohammed A AlzahraniDepartment of Internal Medicine, College of Medicine, King Khalid University.
Ali S AlshamraniMedical Student, College of Medicine, King Khalid University, Abha 61421, Kingdom of Saudi Arabia.
Ibrahim M AhmasaniMedical Student, College of Medicine, King Khalid University, Abha 61421, Kingdom of Saudi Arabia.
Fahad S AlahmariMedical Student, College of Medicine, King Khalid University, Abha 61421, Kingdom of Saudi Arabia.
Ali H AsiriMedical Student, College of Medicine, King Khalid University, Abha 61421, Kingdom of Saudi Arabia.
Abdullah M AlshehriGastroenterologist Consultant, Aseer Central Hospital.
Awad S AlsamghanFamily and Community Medicine Department, College of Medicine, King Khalid university, Abha, Kingdom of Saudi Arabia.
Nabil J AwadallaFamily and Community Medicine Department, College of Medicine, King Khalid university, Abha, Kingdom of Saudi Arabia.ORCID 0000-0002-5687-6621
King Khalid University · SAAmyotrophic Lateral Sclerosis Association · USAsir Central Hospital · SAMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractCoronavirus disease 2019 (COVID-19 pandemic has affected the psychological health of people, causing a higher level of stress. Stress can exaggerate the symptoms of irritable bowel syndrome (IBS).To assess the effect of the COVID-19 pandemic stress on patients with IBS in Saudi Arabia.A descriptive cross-sectional approach was used, which targeted accessible subjects with IBS from different regions of Saudi Arabia. Data were collected from participants using a structured electronic questionnaire, which captured the participants' socio-demographic data, medical history, IBS clinical data, self-reported stress due to COVID-19, and its effect on IBS symptoms.A total of 1255 IBS patients completed the questionnaire. About 63.4% of them reported stress due to the pandemic. The most frequently reported causes of stress were fear of infection occurring in the family, followed by fear of self-infection (43.5%), and death due to COVID-19 infection (17.2%). Most of the stressed participants (56.6%) reported that stress usually exaggerated IBS symptoms. Almost 22% of them consulted a physician for stress aggravation of the symptoms, 18.1% used sedatives due to stress, 9.2% modified IBS medications due to the stress, and 75.5% of the participants reported impaired daily activities due to symptoms exacerbation. Coexisting chronic morbidities and inability to differentiate between COVID-19 gastrointestinal symptoms and IBS symptoms were significantly associated with COVID-19 related stress (P = .039 and .001, respectively).Two-thirds of IBS patients were stressed during the first few months of COVID-19 pandemic. Patients unable to differentiate between COVID-19 gastrointestinal tract symptoms and IBS symptoms, and patients suffering from chronic morbidities were more vulnerable. Pandemic stress exacerbated patients' symptoms and impacted their activities of daily life.

Indexed as

AdultCOVID-19Cross-Sectional StudiesFemaleHumansIrritable Bowel SyndromeMalePandemicsStress, Psychological

Identifiers

PMID33371119
PMCPMC7748344
OpenAlexW3112530902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.